This question tests recognition of potential complications in a post-operative client after hip replacement. Key symptoms include saturated dressing, blood pooling, tachycardia, hypotension, and low hematocrit, indicating blood loss. Hemorrhage leading to hypovolemic shock (A) accurately reflects the risk from excessive bleeding post-surgery. Urinary retention (B), constipation (C), and atelectasis (D) are possible but not supported by symptoms. Early recognition of bleeding and vital instability prevents shock. Prioritizing transfusion and surgical consultation is essential. A transferable strategy is to inspect dressings and monitor hematocrit in orthopedic post-op clients.

This question tests recognition of potential complications in a post-operative client after cholecystectomy. Key symptoms include increasing abdominal pain, lightheadedness, tachycardia, hypotension, and decreasing hemoglobin, signaling instability. Blood pressure 92/58 mm Hg with tachycardia and decreasing hemoglobin (B) accurately reflects hemorrhage, a critical post-surgical complication needing immediate attention. Incisional discomfort (A) is expected; absent bowel sounds (C) are normal early post-op; low temperature with dry mucosa (D) may indicate dehydration but not urgency. Early recognition of vital sign changes and lab trends prevents hypovolemic shock. Prioritizing hemodynamic stability guides interventions like fluid resuscitation. A transferable strategy is to monitor post-operative vital signs and hemoglobin levels hourly initially to identify bleeding complications promptly.

This question tests recognition of potential complications in a client receiving IV potassium. Key symptoms include burning pain, blanching, and swelling at the site, suggesting irritant effects. Swelling and blanching at the IV site with burning pain (A) accurately reflects infiltration or extravasation, risking tissue necrosis. Elevated heart rate post-ambulation (B) is expected; stable blood pressure (C) is normal; warm skin (D) indicates hydration. Early recognition prevents compartment syndrome. Decision-making involves stopping infusion and applying compresses. A transferable strategy is to dilute irritants and monitor sites closely during electrolyte infusions.

This question tests recognition of potential complications in a client with type 1 diabetes after insulin and vomiting. Key symptoms include rapid breathing, abdominal pain, hyperglycemia, and positive ketones, signaling acidosis. Diabetic ketoacidosis with metabolic acidosis (A) accurately reflects the risk from insulin deficiency and ketosis. Hypoglycemia (B) involves low glucose; SIADH (C) causes hyponatremia; pulmonary edema (D) lacks fluid overload signs. Early recognition of Kussmaul breathing and ketones prevents coma. Decision-making includes insulin and fluids. A transferable strategy is to test for ketones in diabetic clients with nausea and hyperglycemia.

This question tests recognition of potential complications in clients with dysphagia and impaired swallowing. The key symptoms indicating risk are wet cough after meals, coarse crackles in right lower lung, fever (101.2°F), and elevated WBC count (12,900/mm³), which strongly suggest aspiration of food/liquids into the lungs. Option A correctly identifies aspiration pneumonia as the complication, evidenced by the temporal relationship between eating and respiratory symptoms plus signs of infection. Option B (pulmonary edema) would present with bilateral crackles and cardiac symptoms, option C (UTI) doesn't explain the respiratory findings, and option D (atelectasis alone) wouldn't cause fever and leukocytosis. The principle for early recognition is that post-meal coughing with unilateral lung findings indicates aspiration before pneumonia fully develops. A transferable monitoring strategy is to observe clients with dysphagia during and after meals for coughing, voice changes, or respiratory distress that suggest aspiration.

This question tests recognition of potential complications related to anticoagulation therapy. The key symptoms indicating risk are INR 5.2 (therapeutic range 2.0-3.0), melena (dark tarry stools indicating GI bleeding), and gum bleeding, which together indicate warfarin toxicity with active bleeding. Option A correctly identifies the supratherapeutic INR with bleeding manifestations as the complication requiring immediate vitamin K administration and possible blood products. Option B (normal oxygen saturation), option C (normal temperature), and option D (history of atrial fibrillation) are expected findings that don't indicate complications. The principle for early recognition is that INR above therapeutic range with any bleeding symptoms indicates anticoagulation-related hemorrhage requiring reversal. A transferable monitoring strategy is to correlate INR values with clinical bleeding signs, as even minor bleeding with elevated INR can progress to major hemorrhage.

This question tests recognition of potential complications related to insulin therapy and diabetes management. The key symptoms indicating risk are shakiness, sweating, tachycardia (HR 112/min), and critically low blood glucose (54 mg/dL) after taking rapid-acting insulin without adequate food intake. Option B correctly identifies hypoglycemia leading to seizure or loss of consciousness as the immediate risk, as glucose below 70 mg/dL can rapidly progress to neuroglycopenic symptoms. Option A (diabetic ketoacidosis) occurs with hyperglycemia not hypoglycemia, option C (hyperglycemia) contradicts the low glucose reading, and option D (chronic neuropathy) is a long-term complication unrelated to acute symptoms. The principle for early recognition is that symptomatic hypoglycemia with glucose below 70 mg/dL requires immediate treatment to prevent neurological complications. A transferable monitoring strategy is to assess for both autonomic symptoms (shakiness, sweating, tachycardia) and glucose levels when clients report changes after insulin administration.

This question tests recognition of potential complications in elderly clients with chronic lung disease. The key symptoms indicating risk are new confusion, fever (100.9°F), decreased oxygen saturation (90%), tachypnea (RR 24/min), and elevated WBC count (13,800/mm³), which suggest acute respiratory infection. Option A correctly identifies the combination of new confusion with fever and decreased oxygen saturation as indicators of pneumonia, a serious complication in COPD patients requiring prompt antibiotic therapy. Option B (chronic morning cough) represents baseline COPD symptoms, option C (normal blood pressure) is not concerning, and option D (mild tachycardia with activity) is expected. The principle for early recognition is that mental status changes with fever and hypoxemia indicate respiratory infection before severe respiratory failure develops. A transferable monitoring strategy is to compare current symptoms to baseline function, as subtle changes like confusion often precede obvious respiratory distress in elderly clients.

This question tests recognition of potential complications during heparin therapy for deep vein thrombosis. The key symptoms indicating risk are elevated aPTT (98 seconds, therapeutic 60-80), new headache, increasing bruising at venipuncture sites, and elevated blood pressure, which suggest heparin overdose with bleeding risk. Option A correctly identifies heparin-induced bleeding including possible intracranial hemorrhage as the complication, as headache with hypertension and supratherapeutic aPTT raises concern for cerebral bleeding. Option B (recurrent DVT) would occur with subtherapeutic levels, option C (pulmonary infection) lacks supporting symptoms, and option D (hypoglycemia) is unrelated to heparin therapy. The principle for early recognition is that neurological symptoms with laboratory evidence of over-anticoagulation indicate potential intracranial bleeding before catastrophic hemorrhage. A transferable monitoring strategy is to assess for both obvious bleeding (bruising) and subtle signs (headache, mental status changes) when aPTT exceeds therapeutic range.

This question tests recognition of potential complications in type 1 diabetes with missed insulin doses. The key symptoms indicating risk are hyperglycemia (486 mg/dL), Kussmaul respirations (deep, rapid breathing), fruity breath odor, low bicarbonate (14 mEq/L), and hypotension, which are pathognomonic for diabetic ketoacidosis. Option A correctly identifies DKA with metabolic acidosis as the complication, evidenced by the classic triad of hyperglycemia, ketosis (fruity breath), and acidosis (low bicarbonate). Option B (hypoglycemia) contradicts the elevated glucose, option C (allergic reaction) would present with skin manifestations, and option D (orthostatic hypotension alone) doesn't explain the metabolic derangements. The principle for early recognition is that hyperglycemia with acidosis and ketosis indicates DKA requiring immediate insulin and fluid resuscitation. A transferable monitoring strategy is to assess for the DKA triad (hyperglycemia, ketosis, acidosis) in any type 1 diabetic with illness or missed insulin doses.